Edward W. Boyer, MD, PhD

Assistant in Medicine

Lecturer on Pediatrics

    Contact: 617-355-4829
  • Fax: 617-730-0521

Medical Services

Specialties

  • Medical Toxicology

Departments

  • Medicine

Programs

  • Regional Center for Poison Control and Prevention
  • Medical Toxicology Program
To schedule an appointment: Call 617-355-4829

Experience and Education

Education

Medical School

Columbia College of Physicians and Surgeons, 1995

New York, NY

Internship

Medical College of Pennsylvania, 1995-1996

Philadelphia, PA

Residency

Hospital of the University of Pennsylvania, 1996-1999

Philadelphia, PA

Fellowship

Boston Children's Hospital, 1999-2001

Boston, MA

Certifications

  • Emergency Medicine, Medical Toxicology

Publications

Publications powered by Harvard Catalyst Profiles
  1. Lydecker AG, Sharma A, McCurdy CR, Avery BA, Babu KM, Boyer EW. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine. J Med Toxicol. 2016 Oct 17.
  2. Riederer AM, Campleman SL, Carlson RG, Boyer EW, Manini AF, Wax PM, Brent JA. Acute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016 Jul 15; 65(27):692-5.
  3. Haran JP, Wu G, Bucci V, Fischer A, Keang L, Boyer EW, Hibberd PL. Antibiotic-associated diarrhoea in emergency department observation unit patients. Epidemiol Infect. 2016 Jul; 144(10):2176-83.
  4. Ranney ML, Freeman JR, Connell G, Spirito A, Boyer E, Walton M, Guthrie KM, Cunningham RM. A Depression Prevention Intervention for Adolescents in the Emergency Department. J Adolesc Health. 2016 Oct; 59(4):401-10.
  5. Lamy FR, Daniulaityte R, Sheth A, Nahhas RW, Martins SS, Boyer EW, Carlson RG. "Those edibles hit hard": Exploration of Twitter data on cannabis edibles in the U.S. Drug Alcohol Depend. 2016 Jul 1; 164:64-70.
  6. Ranney ML, Patena JV, Nugent N, Spirito A, Boyer E, Zatzick D, Cunningham R. PTSD, cyberbullying and peer violence: prevalence and correlates among adolescent emergency department patients. Gen Hosp Psychiatry. 2016 Mar-Apr; 39:32-8.
  7. Carreiro S, Fang H, Zhang J, Wittbold K, Weng S, Mullins R, Smelson D, Boyer EW. iMStrong: Deployment of a Biosensor System to Detect Cocaine Use. J Med Syst. 2015 Dec; 39(12):186.
  8. Chai PR, Babu KM, Boyer EW. The Feasibility and Acceptability of Google Glass for Teletoxicology Consults. J Med Toxicol. 2015 Sep; 11(3):283-7.
  9. Carreiro S, Smelson D, Ranney M, Horvath KJ, Picard RW, Boudreaux ED, Hayes R, Boyer EW. Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol. 2015 Mar; 11(1):73-9.
  10. Rosen, R.K., Ranney, M. and Boyer, EW. (2015).,. Proceedings of the 48th Annual Hawaii International Conference on System Sciences. Formative research for mHealth HIV adherence: the iHAART app. 2015; 2779-85.
  11. Show all
  12. Ranney ML, Thorsen M, Patena JP, Cunningham R, Boyer EW, Walton M, Spirito A, Zatzick D, Morrow K. Proceedings of the 48th Annual Hawaii International Conference on System Sciences. “You need to get them where they feel it’: Conflicting Perspectives on How to Maximize the Structure of Text-Message Psychological Interventions for Adolescents.". 2015; 3247-55.
  13. Chai PR, Wu RY, Ranney ML, Porter PS, Babu KM, Boyer EW. The virtual toxicology service: wearable head-mounted devices for medical toxicology. J Med Toxicol. 2014 Dec; 10(4):382-7.
  14. Haran JP, Hayward G, Skinner S, Merritt C, Hoaglin DC, Hibberd PL, Lu S, Boyer EW. Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics. Am J Emerg Med. 2014 Oct; 32(10):1195-9.
  15. Haran JP, Hoaglin DC, Chen H, Boyer EW, Lu S. Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course. J Clin Virol. 2014 Aug; 60(4):367-73.
  16. Zuckerman M, Weisberg SN, Boyer EW. Pitfalls of intranasal naloxone. Prehosp Emerg Care. 2014 Oct-Dec; 18(4):550-4.
  17. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013; 4:75-82.
  18. Neavyn MJ, Boyer EW, Bird SB, Babu KM. Sodium acetate as a replacement for sodium bicarbonate in medical toxicology: a review. J Med Toxicol. 2013 Sep; 9(3):250-4.
  19. Horvath KJ, Carrico AW, Simoni J, Boyer EW, Amico KR, Petroll AE. Engagement in HIV Medical Care and Technology Use among Stimulant-Using and Nonstimulant-Using Men who have Sex with Men. AIDS Res Treat. 2013; 2013:121352.
  20. Cable CT, Boyer D, Colbert CY, Boyer EW. The writing retreat: a high-yield clinical faculty development opportunity in academic writing. J Grad Med Educ. 2013 Jun; 5(2):299-302.
  21. Abar B, Baumann BM, Rosenbaum CR, Boyer EW, Ziedonis D, Boudreaux ED . Profiles of importance, readiness, and confidence in quitting tobacco use. Journal of Substance Use. 2013; 18:75-81.
  22. Betz M, Sullivan AF, Manton AP, Boyer EW, et al. . Knowledge, attitudes and practices of emergency department providers in the care of suicidal patients. Depression and Anxiety. 2013; 1-8.
  23. Betz M, Miller M, Barber C, Boyer EW, et, al . Lethal means restriction for suicide prevention: Beliefs and behaviors of emergency department providers. Depression and Anxiety. 2013; 1-8.
  24. Davis GG, et al. . National Association of Medical Examiners and American College of Medical Toxicology Expert Panel on Evaluating and Reporting Opioid Deaths. National Association of Medical Examiners Position Paper: Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid Drugs. Acad Forensic Pathol. 2013; 3(1):77-83.
  25. Davis GG, et al. National Association of Medical Examiners and American College of Medical Toxicology Expert Panel on Evaluating and Reporting Opioid Deaths. Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid Drugs. Acad Forensic Pathol. 2013; 3(1):62-76.
  26. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012 Jul 12; 367(2):146-55.
  27. Rosenbaum CD, Boyle KL, Boyer EW. Nasopharyngeal necrosis after chronic opioid (oxycodone/acetaminophen) insufflation. J Med Toxicol. 2012 Jun; 8(2):240-1.
  28. Zuckerman MD, Boyer EW. HIV and club drugs in emerging adulthood. Curr Opin Pediatr. 2012 Apr; 24(2):219-24.
  29. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9.
  30. Levine M, Curry SC, Ruha AM, Pizon AF, Boyer E, Burns J, Bikin D, Gerkin RD. Ethylene glycol elimination kinetics and outcomes in patients managed without hemodialysis. Ann Emerg Med. 2012 Jun; 59(6):527-31.
  31. Weibrecht K, Rhyee S, Manuell ME, Longo C, Boyer EW, Brush E. Sulfur mustard exposure presenting to a community emergency department. Ann Emerg Med. 2012 Jan; 59(1):70-4.
  32. Abar B, Baumann, BM, Rosenbaum CR, Boyer EW, Boudreaux ED. Readiness to change alcohol and illicit drug use among a sample of emergency department patients. Journal of Substance Use. 2012; 17:260-68 .
  33. Ward J, Rosenbaum C, Hernon C, McCurdy CR, Boyer EW. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy? CNS Drugs. 2011 Dec 1; 25(12):999-1007.
  34. Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW. Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol. 2011 Dec; 7(4):281-7.
  35. Ward J, Szabo G, McManus D, Boyer E. Advanced molecular biologic techniques in toxicologic disease. J Med Toxicol. 2011 Dec; 7(4):288-94.
  36. Ward J, Rhyee S, Plansky J, Boyer E. Methoxetamine: a novel ketamine analog and growing health-care concern. Clin Toxicol (Phila). 2011 Nov; 49(9):874-5.
  37. Levine M, Brooks DE, Truitt CA, Wolk BJ, Boyer EW, Ruha AM. Toxicology in the ICU: Part 1: general overview and approach to treatment. Chest. 2011 Sep; 140(3):795-806.
  38. Wachholtz A, Gonzalez G, Boyer E, Naqvi ZN, Rosenbaum C, Ziedonis D. Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil. 2011; 2:145-62.
  39. Moore JO, Boyer EW, Safren S, Robbins GK, Boudreaux ED, Rosen R, Barton B, Moss F. Designing interventions to overcome poor numeracy and improve medication adherence in chronic illness, including HIV/AIDS. J Med Toxicol. 2011 Jun; 7(2):133-8.
  40. Adkins JE, Boyer EW, McCurdy CR. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr Top Med Chem. 2011; 11(9):1165-75.
  41. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6.
  42. Gener B, Burns JM, Griffin S, Boyer EW. Administration of ondansetron is associated with lethal outcome. Pediatrics. 2010 Jun; 125(6):e1514-7.
  43. Boyer EW, McCance-Katz EF, Marcus S. Methadone and buprenorphine toxicity in children. Am J Addict. 2010 Jan-Feb; 19(1):89-95.
  44. Monte AA, Mandell T, Wilford BB, Tennyson J, Boyer EW. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J Addict Dis. 2009 Jul; 28(3):226-31.
  45. Church RJ, Boyer EW. Case files of the Medical Toxicology Fellowship at the University of Massachusetts Medical Center in Worcester, Massachusetts: stumbling through a blue haze. J Med Toxicol. 2009 Mar; 5(1):40-5.
  46. Boyer EW, Wines JD. Impact of Internet pharmacy regulation on opioid analgesic availability. J Stud Alcohol Drugs. 2008 Sep; 69(5):703-8.
  47. Courtney J, Boyer E. Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin. J Med Toxicol. 2008 Sep; 4(3):192-6.
  48. Vitale C, George M, Sheroff A, Hernon C, Boyer E. Tracheal and bronchial obstruction following cyanoacrylate aspiration in a toddler. Clin Toxicol (Phila). 2008 Jul; 46(6):560-2.
  49. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008 Jun; 103(6):1048-50.
  50. Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care. 2007 Nov; 23(11):829-31.
  51. Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, Thomas SH. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007 Sep; 35(9):2071-5.
  52. Boyer EW, Babu KM, Macalino GE, Compton W. Self-treatment of opioid withdrawal with a dietary supplement, Kratom. Am J Addict. 2007 Sep-Oct; 16(5):352-6.
  53. Boyer EW, Lapen PT, Macalino G, Hibberd PL. Dissemination of psychoactive substance information by innovative drug users. Cyberpsychol Behav. 2007 Feb; 10(1):1-6.
  54. Hernon C, Boyer EW, Christensen D, Sugarman S. Case files of the University of Massachusetts fellowship in medical toxicology: three patients with an industrial radiography source exposure. J Med Toxicol. 2006 Dec; 2(4):163-8.
  55. Geib AJ, Babu K, Ewald MB, Boyer EW. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics. 2006 Oct; 118(4):1746-51.
  56. Levine MD, Boyer E. Hyperinsulinemia-euglycemia therapy: a useful tool in treating calcium channel blocker poisoning. Crit Care. 2006; 10(4):149.
  57. Boyer E. Issues in the management of dietary supplement use among hospitalized patients. J Med Toxicol. 2005 Dec; 1(1):30-4.
  58. Lai MW, Boyer EW, Kleinman ME, Rodig NM, Ewald MB. Acute arsenic poisoning in two siblings. Pediatrics. 2005 Jul; 116(1):249-57.
  59. Bird SB, Orr PG, Mazzola JL, Brush DE, Boyer EW. Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factors. J Clin Psychopharmacol. 2005 Jun; 25(3):287-8.
  60. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17; 352(11):1112-20.
  61. Cohen MH, Hrbek A, Davis RB, Schachter SC, Kemper KJ, Boyer EW, Eisenberg DM. Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med. 2005 Feb 14; 165(3):289-95.
  62. Boyer EW, Shannon M, Hibberd PL. The Internet and psychoactive substance use among innovative drug users. Pediatrics. 2005 Feb; 115(2):302-5.
  63. Quang LS, Levy HL, Law T, Desai MC, Maher TJ, Boyer EW, Shannon MW, Woolf AD. Laboratory diagnosis of 1,4-BD and GHB overdose by routine urine organic acid analysis. Clin Toxicol (Phila). 2005; 43(4):321-3.
  64. Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care. 2004 Dec; 20(12):858-63.
  65. Brush DE, Bird SB, Boyer EW. Gamma-hydroxybutyrate use in older adults. Ann Intern Med. 2004 Jun 15; 140(12):W70-1.
  66. Brush DE, Bird SB, Boyer EW. Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. J Toxicol Clin Toxicol. 2004; 42(2):191-5.
  67. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med. 2003 Dec; 10(12):1303-6.
  68. Roblot F, Le Moal G, Godet C, Hutin P, Texereau M, Boyer E, Prazuck T, Lacroix C, Souala MF, Raffi F, Weinbreck P, Besnier JM, Garo B, de Gentile L, Becq-Giraudon B. Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study. J Infect. 2003 Jul; 47(1):19-27.
  69. Boyer EW, Shannon MW. Which drug tests in medical emergencies? Clin Chem. 2003 Mar; 49(3):353-4.
  70. Tong T, Boyer EW. Club drugs, smart drugs, raves, and circuit parties: an overview of the club scene. Pediatr Emerg Care. 2002 Jun; 18(3):216-8.
  71. Boyer EW, Kearney S, Shannon MW, Quang L, Woolf A, Kemper K. Poisoning from a dietary supplement administered during hospitalization. Pediatrics. 2002 Mar; 109(3):E49.
  72. Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning. Pediatr Emerg Care. 2002 Feb; 18(1):36-7.
  73. Brown MJ, Shannon MW, Woolf A, Boyer EW. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001 Oct; 108(4):E77.
  74. Boyer EW, Quang L, Woolf A, Shannon M. Use of physostigmine in the management of gamma-hydroxybutyrate overdose. Ann Emerg Med. 2001 Sep; 38(3):346; author reply 347-8.
  75. Boyer EW, Shannon M, Hibberd PL. Web sites with misinformation about illicit drugs. N Engl J Med. 2001 Aug 9; 345(6):469-71.
  76. Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med. 2001 May 31; 344(22):1721-2.
  77. Boyer EW, Mejia M, Woolf A, Shannon M. Severe ethylene glycol ingestion treated without hemodialysis. Pediatrics. 2001 Jan; 107(1):172-3.
  78. Boyer EW, Quang L, Woolf A, Shannon M, Magnani B. Dextromethorphan and ecstasy pills. JAMA. 2001 Jan 24-31; 285(4):409-10.
  79. Weber JE, Chudnofsky CR, Boczar M, Boyer EW, Wilkerson MD, Hollander JE. Cocaine-associated chest pain: how common is myocardial infarction? Acad Emerg Med. 2000 Aug; 7(8):873-7.
  80. Babu KM, Rosenbaum CD, Boyer EW. Head CT in patient with metabolic acidosis. J Med Toxicol. 2008 Dec; 4(4):275-6.
  81. Brush DE, Boyer EW. Intravenous N-acetylcysteine for children. Pediatr Emerg Care. 2004 Sep; 20(9):649-50.
  82. Weizberg M, Su M, Mazzola JL, Bird SB, Brush DE, Boyer EW. Altered mental status from olanzapine overdose treated with physostigmine. Clin Toxicol (Phila). 2006; 44(3):319-25.
  83. Ali FM, Boyer EW, Bird SB. Estimated risk of hepatotoxicity after an acute acetaminophen overdose in alcoholics. Alcohol. 2008 May; 42(3):213-8.
  84. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila). 2008 Feb; 46(2):146-52.
  85. Boyer EW, Fay RJ, Cook A, Buckosh M, Hibberd PL, Case P. Conducting drug abuse investigations in natural environments: potential directions for medical toxicology research. J Med Toxicol. 2010 Mar; 6(1):56-62.
  86. Burns JM, Marino A, Manno M, Rhyee S, Boyer EW. Status epilepticus in a child secondary to ingestion of skin-lightening cream. Pediatr Emerg Care. 2013 May; 29(5):662-4.
  87. Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, Boyer EW, Smith GA, Sheth A. "Time for dabs": Analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 2015 Oct 01; 155:307-11.
  88. Chai PR, Castillo-Mancilla J, Buffkin E, Darling C, Rosen RK, Horvath KJ, Boudreaux ED, Robbins GK, Hibberd PL, Boyer EW. Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence. J Med Toxicol. 2015 Dec; 11(4):439-44.
  89. Haran JP, Wu G, Bucci V, Fischer A, Boyer EW, Hibberd PL. Treatment of bacterial skin infections in ED observation units: factors influencing prescribing practice. Am J Emerg Med. 2015 Dec; 33(12):1780-5.
  90. McMANUS DD, Chong JW, Soni A, Saczynski JS, Esa N, Napolitano C, Darling CE, Boyer E, Rosen RK, Floyd KC, Chon KH. PULSE-SMART: Pulse-Based Arrhythmia Discrimination Using a Novel Smartphone Application. J Cardiovasc Electrophysiol. 2016 Jan; 27(1):51-7.
  91. Carreiro S, Wittbold K, Indic P, Fang H, Zhang J, Boyer EW. Wearable Biosensors to Detect Physiologic Change During Opioid Use. J Med Toxicol. 2016 Sep; 12(3):255-62.
  92. Chai PR, Rosen RK, Boyer EW. Ingestible Biosensors for Real-Time Medical Adherence Monitoring: MyTMed. Proc Annu Hawaii Int Conf Syst Sci. 2016 Jan; 2016:3416-3423.
  93. Rosen RK, Ranney ML, Boyer EW. Formative research for mhealth HIV adherence: the iHAART app. Proc Annu Hawaii Int Conf Syst Sci. 2015 Jan; 2015:2778-2785.
  94. Ranney ML, Thorsen M, Patena JV, Cunningham RM, Boyer EW, Walton MA, Spirito A, Zatzick DF, Morrow K. "You need to get them where they feel it": Conflicting Perspectives on How to Maximize the Structure of Text-Message Psychological Interventions for Adolescents. Proc Annu Hawaii Int Conf Syst Sci. 2015 Jan; 2015:3247-3255.
To schedule an appointment: Call 617-355-4829
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close